Dr. Wang is a Vice President at Longitude Capital. Prior to joining Longitude Capital in 2022, Dr. Wang was the Senior Director of Strategy & Corporate Development at Dascena, a Longitude portfolio company. Prior to Dascena, Dr. Wang was an Engagement Manager at L.E.K. Consulting where she consulted life sciences companies on drug development, commercial, and portfolio strategy. Dr. Wang holds a PhD in Chemical Biology from UC Berkeley, and a BA in Chemical and Physical Biology from Harvard University.